Cargando…

Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients

BACKGROUND: Smoking cause airway and systemic inflammation and COPD patients present low grade inflammation in peripheral blood. However, data on the influence of smoking itself on systemic inflammation in COPD patients are scarce. This study investigated the association between inflammation, smokin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanni, Suzana E, Pelegrino, Nilva RG, Angeleli, Aparecida YO, Correa, Camila, Godoy, Irma
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891738/ https://www.ncbi.nlm.nih.gov/pubmed/20534161 http://dx.doi.org/10.1186/1476-9255-7-29

Ejemplares similares

Increased production of hydrogen peroxide by peripheral blood monocytes associated with smoking exposure intensity in smokers
por: Tanni, Suzana E, et al.
Publicado: (2012)

Risk Perceptions and Behavior Among Hospitalized Patients With Smoking-Related Diseases
por: Tanni, Suzana E., et al.
Publicado: (2009)

Smoking and Early COPD as Independent Predictors of Body Composition, Exercise Capacity, and Health Status
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

Brief Intervention for Smoking Cessation During Pregnancy
por: Bertani, Andre, et al.
Publicado: (2021)

Predictors of mortality in patients with COPD after 9 years
por: Prudente, Robson, et al.
Publicado: (2018)

Preventing smoking during pregnancy: the importance of maternal knowledge of the health hazards and of the treatment options available
por: Bertani, André Luís, et al.
Publicado: (2015)

Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease
por: Ferrari, Renata, et al.
Publicado: (2013)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2017)

Peripheral Blood Eosinophils and Nine Years Mortality in COPD Patients
por: Prudente, Robson, et al.
Publicado: (2021)

DNA damage and antioxidant capacity in COPD patients with and without lung cancer
por: dos Santos, Camila Freitas, et al.
Publicado: (2022)

Evaluation of Inflammatory Markers in Patients Undergoing a Short-Term Aerobic Exercise Program while Hospitalized due to Acute Exacerbation of COPD
por: Knaut, Caroline, et al.
Publicado: (2020)

Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients
por: Ferrari, Renata, et al.
Publicado: (2015)

Assessment of Aerobic Exercise Adverse Effects during COPD Exacerbation Hospitalization
por: Knaut, Caroline, et al.
Publicado: (2017)

Systemic inflammation in COPD in relation to smoking status
por: Serapinas, Danielius, et al.
Publicado: (2011)

Diagnosing alpha-1 antitrypsin deficiency: does it prevent or improve the course of COPD?
por: Godoy, Irma
Publicado: (2016)

The importance of knowing the home conditions of patients receiving long-term oxygen therapy
por: Godoy, Ilda, et al.
Publicado: (2012)

Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease
por: Ferrari, Renata, et al.
Publicado: (2011)

Dual and Poly Use of Tobacco Products in a Sample of Pregnant Smokers: A Cross-sectional Study
por: Bertani, André Luís, et al.
Publicado: (2023)

Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year
por: Mesquita, Carolina Bonfanti, et al.
Publicado: (2018)

November 18: World COPD Day 2020. Is it a date to celebrate?
por: Batista, Diane Rezende, et al.
Publicado: (2020)

Comparison of morphometry and ventricular function of healthy and smoking young people
por: Batista, Ana Natália Ribeiro, et al.
Publicado: (2020)

Inflammatory Biomarkers Interleukin 1 Beta (IL-1β) and Tumour Necrosis Factor Alpha (TNF-α) Are Differentially Elevated in Tobacco Smoke Associated COPD and Biomass Smoke Associated COPD
por: Shyam Prasad Shetty, Bellipady, et al.
Publicado: (2021)

Evaluation of smoking cessation treatment initiated during hospitalization in patients with heart disease or respiratory disease
por: Garcia, Thaís, et al.
Publicado: (2018)

Nine-Year Follow-Up of Interleukin 6 in Chronic Obstructive Pulmonary Disease – Complementary Results from Previous Studies
por: Prudente, Robson, et al.
Publicado: (2021)

Persistence of systemic inflammation in COPD in spite of smoking cessation
por: Invernizzi, Giovanni
Publicado: (2011)

Different Clusters in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Two-Center Study in Brazil
por: Zucchi, José William, et al.
Publicado: (2020)

Reference values for the incremental shuttle walk test in healthy subjects: from the walk distance to physiological responses ,
por: Dourado, Victor Zuniga, et al.
Publicado: (2013)

Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019
por: Tanni, Suzana Erico, et al.
Publicado: (2023)

Smoking status and second-hand smoke biomarkers in COPD, asthma and healthy controls
por: Bradicich, Matteo, et al.
Publicado: (2020)

Pathogenic mechanism of second hand smoke induced inflammation and COPD
por: Birru, Rahel L., et al.
Publicado: (2012)

Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations
por: Accortt, Neil A, et al.
Publicado: (2017)

Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD
por: Oh, Jee Youn, et al.
Publicado: (2018)

Outcome of Smoking Cessation on Airway Remodeling and Pulmonary Inflammation in COPD Patients
por: Mortaz, Esmaeil, et al.
Publicado: (2011)

Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls
por: Ishikawa, Nobuhisa, et al.
Publicado: (2015)

Differences in systemic inflammation between cigarette and biomass smoke-induced COPD
por: Golpe, Rafael, et al.
Publicado: (2017)

Symptom variability over the course of the day in patients with stable COPD in Brazil: a real-world observational study
por: Cukier, Alberto, et al.
Publicado: (2020)

The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients
por: Principe, Stefania, et al.
Publicado: (2021)

The Lipid Profile and Biochemical Parameters of COPD Patients in Relation to Smoking Status
por: Vicol, Cristina, et al.
Publicado: (2022)

MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men
por: Tsutsumi, Tsubasa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_58glg92pt6ao3d6ge8kame5tah